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Abstract 
Urinary glycosaminoglycans are selectively included 
into calcium oxalate (CaOx) crystals precipitated from 
whole human urine: The presence of glycosaminogly-
cans (GAGs) in the organic matrix of urinary stones, 
and their known effects on CaOx crystallization have 
prompted speculation regarding their role in CaOx uro-
lithiasis. The aim of this study was to examine the 
involvement of GAGs in the early stages of CaOx crys-
tallization in human urine. Urine samples were collect-
ed from healthy men and CaOx crystallization was in-
duced by the addition of a sodium oxalate load. The 
crystals were harvested and demineralized, and the GAG 
content of the resulting extract analysed by cellulose 
acetate electrophoresis. Only one GAG, heparan sul-
phate (HS) was detected in the organic matrix of the 
crystals; chondroitin sulphate (ChS), the most abundant 
urinary GAG, was conspicuously absent. Further exper-
iments, in which varying amounts of HS and ChS were 
added to ultrafiltered (10,000 Da) urine prior to induc-
tion of calcium oxalate crystallization, showed that ChS 
was included into the crystals only when HS was absent 
from the urine. It was concluded that the selective in-
clusion of GAGs into crystals and stones is a function 
related more to relative binding affinity than to ambient 
GAG concentration and that HS and ChS compete for 
specific binding sites on the crystal surface. 
Key Words: Urine, glycosaminoglycans, urolithiasis, 
calcium oxalate, stone matrix, crystal matrix, chon-
droitin sulphate, heparan sulphate, inhibitory activity. 
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Introduction 
All urinary stones, regardless of their mineral con-
tent, contain a network of organic matrix that is distrib-
uted throughout their crystalline structure and accounts 
for 2-6% of their total weight [5, 27, 31]. Because its 
presence would suggest that it may fulfil some directive 
function in the stone's formation, many years of re-
search have been devoted to its study. However, its role 
remains enigmatic, largely because early workers were 
unable to dissolve 75 % of the lyophilized stone matrix, 
and this seriously hampered attempts to characterize its 
component macromolecules [6]. Nonetheless, study of 
the 25 % of matrix which they could dissolve yielded 
some information which at least provided a clue as to 
which macromolecules may be involved in a stone's for-
mation. The major portion of matrix consists of protein 
[4], with the remainder comprising an ill-defined mix-
ture of various materials ranging from "inorganic ash" 
to bacteria and cellular membranes [12]. More recently, 
a second class of macromolecules, the glycosaminogly-
cans (GAGs), have also been detected in matrix [16, 19] 
and these are worthy of particular scrutiny because a 
number of studies have demonstrated that some of them 
are inhibitors of calcium oxalate (CaOx) crystallization 
in aqueous inorganic media [3, 7, 10, 17, 20, 21, 22, 
25]. 
Although a recent study [34] found that the only 
GAG in CaOx stone matrix was heparan sulphate (HS), 
others have previously reported [16] that CaOx dihydrate 
stones contain two GA Gs, namely, HS and hyaluronic 
acid (HA), a finding confirmed by Roberts and Resnick 
[ 19], who also demonstrated the presence of these GA Gs 
both in CaOx monohydrate stones and in those contain-
ing calcium phosphate. Perhaps, the most intriguing 
aspect of these studies is that though both HS and HA 
occur in normal human urine, they are minor constitu-
ents: HA is present in only trace amounts, while HS 
accounts for some 15-20% of the total GAG complement 
[13, 30, 32]. Chondroitin sulphate (CS), on the other 
hand, comprises approximately 60% of urinary GAGs 
[13, 30, 32], but though present in small amounts in 
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both magnesium ammonium phosphate [19) and apatite 
stones [16), it has not been detected in CaOx stone ma-
trix [16, 19, 34). The findings of Nishio et al. [16), 
Roberts and Resnick [19) and Yamaguchi et al. [34) in-
dicate that the inclusion of GAGs into kidney stone ma-
trix does not simply reflect their proportional representa-
tion in human urine. Though this discrepancy may be 
attributable to the relative binding affinities of each 
GAG for the CaOx crystal surface [l, 11), equally, it 
may be the consequence of a number of other factors, 
including difficulties with dissolving matrix, as discussed 
above. Furthermore, identification of matrix GAGs 
like proteins, has been frustrated by the fact that thei; 
molecular structure and properties can be altered by the 
aggressive procedures required for their isolation from 
the stone, ageing, polymerization and their very involve-
ment in the crystallization process [9, 14, 18). To these 
can be added a further complicating factor: macromole-
cules in matrix can derive both from the normal urinary 
complement and from endothelial trauma caused by the 
inchoate or developed stone during its passage through 
the renal collecting system and urinary tract [9]. It is 
possible therefore, that GAGs may be present in matrix 
as a result of the participation of normal urinary GAGs 
in the crystallization of CaOx, the binding to crystal 
surfaces of GAGs released by tissue damage, that are 
not normally present in urine, or both. 
Collectively, these problems have conspired to ob-
scure the role of urinary GAGs in stone pathogenesis. 
However, to a large extent the problems associated with 
the analysis of GAGs in renal stones can be overcome 
by studying those included in CaOx crystals freshly pre-
cipitated from human urine, an approach which has been 
successfully adopted for studying the involvement of uri-
nary proteins in CaOx crystallization [9, 19). The aim 
of this study was therefore to determine which urinary 
GAGs are involved in the formation of CaOx crystals 
newly deposited from fresh human urine. 
Materials and Methods 
Materials 
All reagents were of analytical purity. Unless stated 
otherwise, the biochemicals were purchased from the 
suppliers listed in a previous paper [9]. Chondroitin 
sulphate, heparan sulphate, chondroitinase ABC (EC 
4.2.2.4), heparitinase (EC 4.2.2.8) and D-glucuronic 
acid were obtained from Sigma Chemical Co., St. 
Louis, MO). All solutions were prepared with the high-
est quality water from a "Hi Pure" water purification 
system fitted with a 0.2 µm pore-size filter (Permutit 
Australia, Brookvale, NSW, Australia). Cellulose ace-
tate strips (Sepraphore III, 2.5 x 15.2 cm) were obtained 
from Gelman Sciences (Ann Arbor, MI, USA) and 
stained with Alcian blue (Sigma). 
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Collection and preparation of urine samples 
Twenty four hour urine specimens, refrigerated 
throughout the collection period, were obtained without 
preservative from 5 healthy men aged between 30 and 
43 years. Each specimen was tested to exclude the pres-
ence of blood using Multistix test strips (Miles Labora-
tories, Mulgrave, Victoria, Australia). The samples 
were then pooled and subjected to one of the following 
treatments. Whole urine (WU) was obtained by passing 
the urine through a 20-µm pore-size nylon mesh (Swiss 
Screens; Sydney, Australia; Nytal HD20) to remove cel-
lular debris. Spun and filtered urines (SF) were pre-
pared by centrifugation at 10,000 x g for 30 minutes in 
a J2-21M/E centrifuge (Beckman Instruments, Palo Alto, 
CA), followed by filtration through 0.22-µm pore-size 
filters (GSWP04700; Millipore Corp; Bedford, MA), 
while ultrafiltered urines (UF) were similarly treated 
prior to ultrafiltration using a hollow fibre bundle 
(HlPl0-20; Amicon Corp, Danvers, MA) with a nomi-
nal molecular mass cut-off of 10 kDa. Urine samples 
were refrigerated until required and warmed to 37°C 
immediately prior to use. 
Induction of CaOx crystallimtion 
Preparation of CaOx crystals from urine and isola-
tion of their organic matrix were performed as described 
by Doyle et al. [9], with the urinary metastable limit 
being determined using a modification [28) of the origi-
nal method of Ryall et al. [24). Thirty mmol/1 of sodi-
um oxalate, in excess of the measured metastable limit, 
was added drop-wise to the urine and the specimen was 
incubated in a shaking water bath at 37°C for 1 hour. 
To increase the yield of CaOx crystals, the same amount 
of oxalate was added after 1 hour, and again after 2 
hours. The reaction was carried out for a total of 3 
hours. 
In the initial experiments, HS and ChS were added 
to ultrafiltered urine at final concentrations of 1, 2 and 
10 µglml respectively. 
Isolation of crystal matrix 
Crystals precipitated from the UF urines were iso-
lated by 0.22 µm Millipore filtration. However, those 
deposited from the WU specimens were removed by 
centrifugation at 10,000 x g for 20 minutes in a Beck-
man J2-21M/E centrifuge, because whole human urine 
cannot be filtered [8, 33) owing to the presence of poly-
merized Tamm-Horsfall glycoprotein (THG). The crys-
tals were then washed with 0.1 mol/1 NaOH and distilled 
water to remove any glycosaminoglycans present in the 
small amounts of residual urine associated with the crys-
tals. This step was repeated 6 times prior to their de-
mineralization in 0.25 mol/1 ethylenediarninetetraacetic 
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acid (EDTA) solution (pH 8.0) for three days at 4°C as 
described in detail by Doyle et al. [9]. Following ex-
haustive electrodialysis to remove the EDT A, the demin-
eralized crystal extracts were lyophilized to yield a 
colourless, flocculant material that was processed as 
described below. 
Electrophoresis 
After dissolution of the lyophilized extract (20 µgl 
20 µI of distilled water), 2-5 µI was applied to cellulose 
acetate strips and electrophoresed for 90 minutes in 0.2 
mol/1 of pH 7.2 calcium acetate buffer [29] at a constant 
voltage of 80 V). HS and ChS were run simultaneously 
as standards at a concentration of 1 µ,g/ µl. After elec-
trophoresis, the cellulose acetate strips were stained for 
30 minutes in 0.2 % Alcian blue in 25 mmol/1 sodium 
acetate buffer (pH 5.8), containing 50 mmol/1 magnesi-
um chloride and 50 % ethanol. The membrane was then 
destained in several changes of the same buffer. 
GAGs were provisionally identified by comparing 
the bands on the electrophoretogram with the migration 
distances of the standards included in each run. Identi-
fication was confirmed by digesting the matrix solution, 
prior to electrophoresis, with chondroitinase and hepari-
tinase. Samples of crystal matrix were incubated with 
chondroitinase ABC (0.5 unit of enzyme/100 µg uronic 
acid) in 0.1 mol/1 Tris-RC! buffer (pH 8.0) at 37°C for 
18 hours, or with heparitinase (2 units of enzyme/100 µg 
uronic acid) in acetate buffer (pH 6. 7) at 43 °C for 60 
minutes. Total GAG was estimated by determining 
uronic acid concentration using the method of Blumen-
krantz and Asboe-Hansen [2] using D-glucuronic acid as 
standard. · 
Results 
In all cases, calcium oxalate monohydrate crystals 
were precipitated. Figure 1 shows electrophoretograms 
of HS and ChS standards, matrix extract of CaOx crys-
tals precipitated from whole urine (WU), centrifuged 
and filtered urine (S&F) and ultrafiltered urine to which 
HS (UF+HS) and ChS (UF+ChS) had been added; 
bands are shown before and after heparitinase digestion. 
Only one band was visible in the matrix from the whole 
(WU) and spun and filtered (SF) urines. The band was 
identified as HS, since its migration distance was iden-
tical to that of standard HS, and it disappeared after di-
gestion with heparitinase. It was unaffected by papain 
digestion, suggesting that the HS in the crystals was not 
present as a proteoglycan. 
As expected, no GAG bands were detected in elec-
trophoretograms of the matrix of CaOx crystals deposit-
ed from UF urines. However, when HS was added to 
UF urine at a final concentration of 2 µg/ml, and CaOx 
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Table l. Concentrations of HS and ChS added to 



















crystal formation induced, the electrophoretogram of the 
resulting crystal extract showed the presence of the same 
band as was observed with the extract derived from the 
SF urine. 
Because these results indicated that heparan sulphate 
is selectively included into CaOx crystals to the exclu-
sion of other urinary GAGs, a further experiment was 
carried out where CaOx crystals were precipitated from 
UF urine which had been supplemented with ChS at a 
final concentration of 10 µg/ml. In this case, the elec-
trophoretogram demonstrated the presence of a weakly 
staining band that had the same migration characteristics 
of ChS. This band disappeared after digestion with 
chondroitinase, but not with heparitinase, confirming 
that it was chondroitin sulphate. 
Since this result provided further evidence that the 
inclusion of GAGs into CaOx crystals is selective, and 
suggested that binding of urinary GAGs to the crystal 
surface is competitive, an additional experiment was un-
dertaken in which increasing concentrations of HS and 
ChS were added to samples of the same ultrafiltered 
urine in a grid construction as shown in Table 1. Crys-
tallization was induced by the addition of oxalate as be-
fore, and after isolation of the matrix extract from the 
CaOx crystals precipitated from each of the 16 urine 
samples, the lyophilized materials were dissolved and 
electrophoresed. The electrophoretograms are shown in 
Figure 2. In the absence of any added GAGs, and at 
ChS and HS concentrations of O and 1 µg/rnl, respec-
tively, no bands were visible. ChS was detected in the 
crystal extract only at a final urinary concentration of 10 
µglml, and then, only in the complete absence of HS or 
in the presence of the lowest concentration of HS tested 
(1 µg/ml), where a faint band was visible. In contrast, 
HS was visible in the extract at a concentration of 1 
µglml in the presence of ChS concentrations of 1 and 2 
µg/ml, and was always observed at higher concentra-
tions. Although the results were not quantified, it is 
apparent that the amount of HS incorporated into the 
crystals decreased in relation to increasing concentrations 
of ChS. This effect is most noticeable at an HS concen-
tration of 2 µg/ml. The competition between ChS and 















Figure 1. Cellulose acetate electrophoretograms of standards and GAGs extracted from CaOx crystals precipitated from 
urine, before (a) and after (b) digestion with heparitinase: HS, heparan sulphate standard (1 µg/µl); WU, extract of 
crystals deposited from whole (untreated) human urine; S&F, extract of crystals obtained from urine that had been 
centrifuged and filtered; UF + HS, crystal extract derived from ultrafiltered urine to which HS had been added at a 
final concentration of 2 µglml; UF + ChS, extract of crystals precipitated from ultrafiltered urine that had been 
supplemented with ChS at a final concentration of 10 µglml; ChS, chondroitin sulphate standard (2 µg/µI). No bands 
were visible in extracts of crystals generated in ultrafiltered urine. 
HS 
0 µg/ml 1 µg/ml 2 µg/ml 10 µg/ml 
HS ChS 
0 µg/ml I standard 
ChS 





Figure 2. Cellulose acetate electrophoretograms of extracts of CaOx crystals precipitated from ultrafiltered urine 
supplemented with varying concentrations of ChS and HS. The concentrations refer to the final concentrations of GA Gs 
added to the ultrafiltered urine. Standards are included for comparison (HS, 1 µglml; ChS, 2 µg/ml) as well as the 
electrophoretogram for the extract of the same urine which had been centrifuged and filtered only, and which contained 
no supplementary ChS or HS. 
HS can also be seen at an HS concentration of 1 µg/ml 
in the presence of 10 µglml ChS, where the 10-fold 
greater concentration of the latter appears to have pre-
vented the inclusion of HS, which was observed at lower 
concentrations of ChS. 
526 
Crystals precipitated from the same urine which had 
been spun and filtered, but not ultrafiltered, contained 
only HS, confirming the findings of the first part of this 
study. 
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Discussion 
More than twenty years have elapsed since Craw-
ford et al. [7] showed that the crystallization of calcium 
oxalate (CaOx) is inhibited by synthetic and natural 
GAGs. Their observation, and the fact that GAGs occur 
naturally in urine, have since prompted numerous work-
ers to investigate the possibility that these molecules may 
play a determinant role in stone pathogenesis. This pos-
sibility was later strengthened by the detection of GAGs 
in urinary stones [16, 19, 34], but was confused some-
what by the observation of a mismatch between the rela-
tive amounts of specific GAGs in urine and calculi. The 
GAGs present in CaOx stones, HS and HA [16, 19, 34], 
are only minor urinary constituents, while the most 
abundant urinary GAG, ChS, has not been detected in 
stone matrix. One explanation for this discrepancy is 
that matrix GAGs, like proteins [9], may possibly derive 
from two distinct sources. First, normal urinary GAGs 
may bind to the surface of newly formed crystals in the 
renal collecting system; provided the urine remains suf-
ficiently supersaturated, they will then become embedded 
within the crystal architecture as new mineral is deposit-
ed upon the crystal surface. Second, it is possible that 
once crystals have formed, their very presence in the 
urinary tract may alter the GAG content of urine by 
damaging the urothelium and causing the release of 
GAGs in relative quantities quite different from their 
normal proportional complement in urine. These GAGs 
may now bind to the surface of the crystals, and as stone 
development occurs, these too will become incorporated 
within the stone structure. It is possible therefore that, 
despite its low concentration in urine, HS may be pre-
sent in stones because large amounts of it are released in 
response to urothelial injury, not because it plays some 
active role in the precipitation of CaOx crystals from 
urine. It is important to distinguish between the two 
mechanisms of GAGs inclusion because in one case the 
GAGs may have contributed to the formation of the cal-
culus, while in the other they are a product of it. 
In the present study, the complicating factor of 
GAGs derived from tissue trauma was avoided by study-
ing the GAG component of CaOx crystals freshly pre-
cipitated from human urine, an approach that has been 
successfully adopted to study the role of urinary proteins 
in matrix [9, 15]. It was found that GAGs are present 
in CaOx crystals even when precipitation takes place in 
the presence of other urinary macromolecular competi-
tors such as proteins, suggesting that binding takes place 
on specific sites on the crystalline surfaces. Only one 
urinary GAG, HS, was included into the crystals. 
GAGs in CaOx crystals are therefore identical to those 
in CaOx stones: Nishio et al. [16] showed that the solu-
ble matrix of CaOx dihydrate stones contained HS and 
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HA, and similar results were later reported for CaOx 
monohydrate stones [19] although more recent findings 
[34] showed that HA is not present in stones. Thus, 
even if GAGs are released into urine in response to uro-
thelial trauma, their qualitative incorporation into stones 
is identical to that into freshly deposited crystals, indicat-
ing that their presence in matrix is more a function of 
selectivity than of quantity. This selectivity can be as-
cribed to the fact that different GAGs possess different 
binding affinities for the CaOx crystal surface. Fell-
strom et al. [11] measured the relative binding affinities 
of a number of GAGs to calcium oxalate crystals in in-
organic media and reported that, in addition to ionic 
strength, the binding affinity of each GAG was directly 
related to its charge density in the order: pentosan 
polysulphate (a synthetic GAG) > heparin (not present 
in human urine) > ChS. They also demonstrated that 
the inhibitory potency of these GAGs decreased in the 
same order [10], and concluded that the inhibitory activi-
ty of GAGs is largely a function of their charge density. 
Later, Angell and Resnick [1] also showed that GAGs 
differ in their binding affinity for CaOx, but obtained 
different results: heparin > HA > ChS > pentosan 
polysulphate. The discrepancy in the order of binding 
affinity may perhaps result from differences in methodo-
logy used. Nonetheless, both studies confirm that differ-
ent GAGs do not bind with equal strength and this may 
explain the selective incorporation of HS into stones and 
CaOx crystals at the expense of ChS. 
It is noteworthy that the selectivity of GAGs inclu-
sion into stones, observed independently by three differ-
ent research groups and now confirmed in this study us-
ing CaOx crystals, was ascribed to completely opposite 
causes. The fact that ChS could not be detected in stone 
matrix, coupled with earlier observations that it inhibits 
CaOx crystallization, prompted Nishio et al. [16] to con-
clude that HS and HA, which were present in the ma-
trix, must be promoters of stone formation. Paradoxi-
cally however, Roberts and Resnick [19] on the basis of 
identical findings, suggested the contrary interpretation. 
They attributed the presence of HS and HA in stone ma-
trix to their strong binding affinity for the surface of the 
crystals comprising the stone, and since it is generally 
accepted that the magnitude of an inhibitor's effect is a 
function of the efficiency of its binding to the crystal 
surface, they implied in their discussion that HS and HA 
normally fulfil an inhibitory role in urine. Yamaguchi 
et al. [34] arrived at the same conclusion; they inferred 
from their results that HS strongly inhibits CaOx crystal 
growth and aggregation, since HS was the only GAG 
present in soluble stone and crystal matrices, which ex-
hibited strong inhibitory effects in their study. More re-
cent! y, however, evidence has been obtained that urinary 
GAGs can exert a dual effect on CaOx crystallization, 
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promoting crystal nucleation, while at the same time re-
ducing the final size of the crystals produced. Thus, 
Shum and Gobel [26) showed that, at the same uronic 
acid concentration, both ChS and HS enhanced CaOx 
nucleation from frozen ultrafiltered urine, whereas only 
HS derived from controls exhibited the effect. Similar-
ly, they reported that crystals precipitated from frozen 
ultrafiltered urine samples to which HS had been added 
were smaller than those deposited in the presence of 
ChS, irrespective of whether the GAGs were isolated 
from stone formers or controls. Those findings are con-
sistent with those reported here. The greater inhibitory 
effect of HS is not unexpected, since it bears structural 
similarities to heparin [10, 11), unlike ChS, which has 
no measurable effect on CaOx crystallization in ultrafil-
tered, undiluted human urine [23). Moreover, it can be 
argued that enhancement of crystal nucleation can be 
beneficial, since it is well recognised that rapid nuclea-
tion gives rise to smaller crystals; such crystals would be 
more easily and quickly flushed from the urinary tract 
and thereby reduce the probability of crystal retention 
and stone formation. 
In addition to demonstrating that the inclusion of 
urinary GAGs into CaOx crystals is a selective phenom-
enon, the present study also represents the first attempt 
to examine the relative binding affinities of HS and ChS 
in undiluted human urine, a medium in which their bind-
ing properties are more likely to reflect their binding 
properties in vivo. This was done by systematically in-
creasing the relative amounts of HS and ChS added to 
ultrafiltered urine before inducing CaOx crystallization. 
The data indicated that when binding does occur, the 
amount of GAG bound is directly proportional to the 
ambient concentration; for instance, although not quanti-
fied, it was apparent that the amount of HS incorporated 
into the crystals increased in response to increasing con-
centrations of exogenous HS in the ultrafiltered urine to 
which it was added. It was also apparent that the bind-
ing affinity of ChS was very much less than that of HS; 
ChS was only detectable in the crystals when its concen-
tration in the ultrafiltered urine was 10 µg/ml, in con-
trast to HS, which was visible in crystals generated in 
the presence of a concentration of 2 µg/ml. The relative 
binding affinities of ChS and HS in undiluted urine are 
therefore the same as those reported for inorganic solu-
tions [l, 10). The present studies also demonstrated that 
ChS can bind to CaOx crystals and become included into 
crystals precipitated from urine. The fact that this only 
occurs in the absence of HS suggests that HS and ChS 
compete for the same binding sites on the crystal sur-
faces. Since evidence would indicate that HS may fulfil 
an inhibitory role in CaOx stone pathogenesis, as dis-
cussed above, it is attractive to speculate that in vivo 
ChS may compensate for a deficiency of HS in the 
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urine. However, this is doubtful in view of the fact that 
ChS does not affect CaOx crystallization in undiluted, 
ultrafiltered human urine [23) at a final concentration of 
20 µglml, a concentration double that used in the present 
study. 
In summary therefore, the present study has demon-
strated that urinary GAGs are involved in the critical 
crystallization stage of stone formation. The inclusion 
of GAGs into CaOx crystals precipitated from undiluted 
human urine is a selective process and, as with urinary 
stones, HS is incorporated in preference to ChS, despite 
the fact that ChS is present in urine at a concentration 
approximately 4 times greater than that of HS [13, 30, 
32). Furthermore, even if a proportion of GAGs in 
stones is derived from those released into urine as a re-
sult of tissue damage caused by the stones themselves, 
it is apparent that only HS binds strongly enough to be 
included in the fully developed structure. The routine 
measurement of total urinary GAGs excretion is there-
fore unlikely to be of any practical benefit in the diag-
nosis and management of urolithiasis, a point made pre-
viously by Fellstrom et al. [10). However, the mere 
presence of HS in kidney stones does not presuppose a 
critical function for it in calculus formation; it may sim-
ply be a passive adsorbent that binds non-specifically to 
the inorganic crystal phase, rather than an active protag-
onist in the crystallization process. Furthermore, even 
if the involvement of HS in the crucial crystallization 
stage of stone formation is directive, paradoxically, it 
may be either as an inhibitor or promoter. Future stud-
ies should therefore be aimed at determining whether the 
presence of HS in crystals and stones is a consequence 
of its acting as an inhibitor or promoter of CaOx crystal-
lization, or whether it is simply a disinterested partici-
pant in the process. 
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Discussion with Reviewers 
S. Yamaguchi: In general, both glycosaminoglycans 
and urinary proteins adsorb on CaOx crystals in whole 
urine. Do these proteins and heparan sulphate compete 
for the same binding sites on the crystals? 
Authors: We have not performed competitive binding 
studies between GAGs and proteins and so cannot pro-
vide a definite answer to this question. However, even 
if they do compete, it is apparent that binding of neither 
type of macromolecule completely prohibits adsorption 
of the other, since the organic matrix of calcium oxalate 
crystals precipitated from whole urine, contains both HS 
(as shown in this paper) and proteins (as shown in refer-
ence 9). This could suggest that HS and proteins do not 
compete for the same binding sites on the crystals. Al-
ternatively however, it is possible that either HS or pro-
teins could first be adsorbed in the early stages of crys-
tallization, but that subsequent deposition of CaOx is 
sufficient to bind the other in the later stages of crystal 
growth. 
S. Yamaguchi: What do you think of the selective in-
corporation of heparan sulphate into CaOx crystals? Is 
it simple incorporation or specific incorporation? 
Authors: The fact that HS is incorporated into CaOx 
crystal matrix is evidence that the GAG binds to the 
crystal surface, but whether this binding is simple (non-
specific) or occurs at specific sites cannot be stated with 
certainty from our data. Nonetheless, the fact that HS 
is incorporated to the exclusion of ChS, suggests that the 
process is competitive, and this in tum implies that the 
binding is specific, rather than indiscriminate. 
S.R. Khan: Since crystalluria is common in both stone 
formers and non-stone formers, why do you consider 
crystallization a critical event in stone formation? 
Authors: In so far as stone formation can never occur 
without crystal nucleation, this event may be regarded as 
the critical step in the crystallization process . That is 
not to say, of course, that subsequent steps are not also 
crucial; there is good evidence that the process of crystal 
aggregation is also vital in determining whether or not 
crystalluria will proceed to stone formation. 
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S. Nishio: The present study showed that heparan sul-
fate was selectively included into calcium oxalate crys-
tals in the presence of both heparan sulfate and chondro-
itin sulfate. Did you examine the influence of urinary 
pH? 
Authors: No, we did not examine the influence of pH. 
All urines were used at their native pH. 
J.P. Binette: Papain digestion, had it displaced the HS 
band, would have complicated matters and cannot ex-
clude the peptide moiety in this system. Why were 
GAGs not expected from CaOx crystals deposited from 
UF urines? 
Authors: Had the HS band been altered after hepari-
tinas treatment, it might have indicated that the binding 
affinity of HS for the crystal surface was dependent 
upon its being linked to a protein moiety. GAGs were 
not expected from crystals precipitated from ultrafiltered 
urine because all macromolecules with molecular mass 
> 10 kDa were removed by the ultrafiltration process. 
J.P. Binette: ChS is detected in the matrix of some 
stones. The statement that GAGs are a product of the 
calculus is succinct and incorrect. GAGs maybe dis-
lodged from tissue by sharp crystals or aggregates to 
which they may bind and thus rejoin the formation of 
the calculus. 
Authors: I am aware of no study that has conclusively 
demonstrated the presence of ChS in calcium oxalate 
stone matrix, although it has been detected in magne-
sium ammonium phosphate stones [19] and is present in 
small amounts in apatite calculi [16]. The statement that 
there are two possible mechanisms of GAGs inclusion 
into the matrix of stones may well be succinct, but it is 
not incorrect. In fact, Dr. Binette's remark that GAGs 
"may be dislodged from tissue by sharp crystals or ag-
gregates to which they may bind and thus rejoin the for-
mation of the calculus" completely supports the argu-
ment. Normal urinary GAGs may be present in crys-
tals/stones because they have been involved in the crys-
tallization process: they are forerunners to nucleation. 
On the other hand, GAGs not normally present in urine, 
but which are released by tissue injury caused by crys-
tals or the growing stone, may also then bind to the 
crystals and become part of the final stone structure, 
these GAGs are products of the developing stone which 
later become part of the final urolith. 
